DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Glaucoma - Pipeline Review, H1 2016" drug pipelines to their offering.
The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- The report provides a snapshot of the global therapeutic landscape of Glaucoma
- The report reviews pipeline therapeutics for Glaucoma by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Glaucoma therapeutics and enlists all their major and minor projects
- The report assesses Glaucoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
Companies Mentioned Include:
- AC Immune SA
- Acadia Pharmaceuticals Inc.
- Advanced Refractive Technologies, Inc.
- Aerie Pharmaceuticals, Inc.
- Allergan Plc
- Altacor Limited
- Kadmon Corporation, LLC
- Kala Pharmaceuticals, Inc.
- Kowa Company, Ltd.
- Kukje Pharmaceutical Industry Co., Ltd.
- Lee's Pharmaceutical Holdings Limited
- Regeneron Pharmaceuticals, Inc.
- Sanofi
- Santen Pharmaceutical Co., Ltd.
- Senju Pharmaceutical Co., Ltd.
- Shire Plc
- SK Biopharmaceuticals Co., Ltd.
- Sun Pharma Advanced Research Company Ltd.
- Sylentis S.A.U.
- UAB Profarma
- ViSci Ltd.
- vTv Therapeutics LLC
For more information visit http://www.researchandmarkets.com/research/4hkk8b/glaucoma
